Grove's First GAAP Profit Quarter Comes With Thin Liquidity and a Fresh NYSE Notice
GROV sits 22% above its 52-week low of $0.863 on light trading volume (0.3× avg).
Summary
Grove posted its first GAAP profit ($0.1M net income, $1.4M Adjusted EBITDA) on $36.8M of revenue, but the 10-Q shows only $8.0M of cash, $2.1M of revolver headroom, a probable-but-unestimable CART auto-renewal loss, and a renewed NYSE market-cap compliance notice.
Key Events · Earnings and Guidance · GROV
-
First GAAP Profit Quarter
Q3 2026 net income was $0.1M versus a $2.96M net loss a year earlier; Adjusted EBITDA was $1.35M (3.7% margin), helped by a $1.2M IEEPA tariff refund recognized as a reduction of cost of goods sold.
-
Revenue Down 16% YoY
Net revenue fell to $36.8M from $43.7M as DTC active customers dropped 30.6% to 458,000; advertising expense was cut 43% to $1.8M, and gross margin rose to 56% from 53%.
-
Thin Liquidity and Revolver Headroom
Unrestricted cash was $8.0M at September 30, 2026, with $7.5M drawn on the $35.0M Siena Revolver leaving $2.1M of additional borrowing capacity; nine-month operating cash flow was positive $838K.
-
CART Auto-Renewal Probe
The California Autorenewal Task Force investigation makes a loss probable, but the company cannot estimate the amount; an unfavorable outcome could be material.
Analysis · GROV · Trade & Services
A $0.1M net income quarter is a genuine milestone for Grove, but the 10-Q reveals how thin the cushion is: $8.0M of unrestricted cash, $7.5M drawn on the revolver leaving only $2.1M of borrowing headroom, and roughly $6.8M of remaining SEPA capacity as of October 31, 2026. The profit also leans on a one-time $1.2M tariff refund that cut cost of goods sold, while revenue fell 16% to $36.8M as active customers dropped 30.6% to 458,000. Two overhangs sit alongside the results: a California district attorney task force investigating auto-renewal practices, where a loss is probable but not estimable, and an August 7, 2026 NYSE notice that the company again fell below the $50M market cap/equity standard — the exchange accepted its cure plan on November 4, 2026, leaving a nine-month window to comply.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GROV was trading at $1.05 on NYSE in the Trade & Services sector, with a market capitalization of approximately $44.4M. The 52-week trading range was $0.86 to $1.55. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.